论著

肝脏E-钙黏蛋白过表达对日本血吸虫感染小鼠肝纤维化的影响

  • 姜婷婷 ,
  • 蔚志豪 ,
  • 崔轩胤 ,
  • 莫筱瑾 ,
  • 李显 ,
  • 胡媛
展开
  • 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心), 传染病溯源预警与智能决策全国重点实验室,国家卫生健康委员会寄生虫病原与媒介生物学重点实验室,世界卫生组织热带病合作中心,科技部国家级热带病国际联合研究中心, 上海 200025
姜婷婷,女,博士研究生,从事寄生虫感染与免疫研究。E-mail:jiangtingt16@163.com
* 胡媛(ORCID: 0000-0002-5439-8822),女,博士,研究员,从事寄生虫感染与免疫研究。E-mail:huyuan@nipd.chinacdc.cn

收稿日期: 2025-10-22

  修回日期: 2025-12-06

  网络出版日期: 2026-02-12

基金资助

上海市自然科学基金(23ZR1469500)

Impact of hepatic E-cadherin overexpression on liver fibrosis in mice infected with Schistosoma japonicum

  • JIANG Tingting ,
  • YU Zhihao ,
  • CUI Xuanyin ,
  • MO Xiaojin ,
  • LI Xian ,
  • HU Yuan
Expand
  • National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention; Chinese Center for Tropical Diseases Research; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases; NHC Key Laboratory on Parasite and Vector Biology; WHO Collaborating Centre for Tropical Diseases; National Center for International Research on Tropical Diseases, Ministry of Science and Technology, Shanghai 200025, China

Received date: 2025-10-22

  Revised date: 2025-12-06

  Online published: 2026-02-12

Supported by

Natural Science Foundation of Shanghai(23ZR1469500)

摘要

目的 探究E-钙黏蛋白(E-cad)过表达对血吸虫感染引起的肝组织上皮间质转化(EMT)和纤维化的影响。 方法 16只小鼠随机分为E-cad组和对照组,分别经尾静脉注射2 × 1011 vg的腺相关病毒8包装的E-cad质粒和空质粒。注射后3周,经腹部贴片法感染日本血吸虫尾蚴[(20 ± 1)条/只],感染后6周取肝组织。提取肝组织RNA,qPCR检测目的基因的相对转录水平。提取肝组织蛋白,蛋白质免疫印迹(Western blotting)检测目的蛋白的相对表达水平。肝组织石蜡切片行苏木精-伊红(HE)染色和Masson染色,计算单个虫卵肉芽肿面积和胶原纤维面积。使用GraphPad Prism 9软件进行统计学分析,两组比较采用t检验。 结果 对照组和E-cad组小鼠肝组织中E-cad的mRNA相对转录水平分别为1.15 ± 0.07、7.19 ± 2.43,E-cad的蛋白相对表达水平分别为1.03 ± 0.16、1.42 ± 0.22,E-cad组均高于对照组(t = 4.30、3.62,P < 0.05、0.01),肝脏过表达E-cad小鼠模型构建成功。qPCR结果显示,E-cad组小鼠肝组织中波形蛋白(Vim)、α-平滑肌肌动蛋白(α-SMA)、Ⅰ型胶原蛋白(Col-1)和Ⅲ型胶原蛋白(Col-3)的mRNA相对转录水平分别为0.60 ± 0.17、0.62 ± 0.19、0.31 ± 0.17、0.30 ± 0.13,均低于对照组的1.37 ± 0.33、1.43 ± 0.35、1.78 ± 0.84、1.78 ± 0.45(t = 3.60、3.48、3.74、5.52,P < 0.05、0.05、0.05、0.01)。Western blotting结果显示,E-cad组小鼠肝组织中Vim、N-钙黏蛋白(N-cad)、α-SMA、Col-1、Col-3、转化生长因子β1(TGF-β1)、Samd2和Smad3的蛋白相对表达水平分别为0.22 ± 0.13、0.37 ± 0.14、0.29 ± 0.19、0.23 ± 0.06、0.17 ± 0.02、0.32 ± 0.13、0.57 ± 0.14和0.54 ± 0.10,均低于对照组的0.71 ± 0.13、0.65 ± 0.08、0.81 ± 0.13、0.43 ± 0.08、0.50 ± 0.16、0.68 ± 0.07、0.87 ± 0.04、0.82 ± 0.06(t = 4.39、2.75、3.91、3.99、3.47、3.92、2.95、4.61,P < 0.01、0.05、0.01、0.01、0.05、0.01、0.05、0.05)。HE染色显示,对照组和E-cad组小鼠的肝组织单卵肉芽肿面积分别为[(34.10 ± 6.94) ×104]和[(12.76 ± 3.16) × 104]μm2;Masson染色显示,对照组和E-cad组小鼠的肝组织单卵肉芽肿胶原纤维面积分别为[(8.50 ± 2.36) × 104]和[(3.65 ± 0.90) × 104]μm2。E-cad组的单卵肉芽肿面积和胶原纤维面积均小于对照组(t = 7.41、5.01,均P < 0.01)。 结论 小鼠肝脏过表达E-cad能够减轻日本血吸虫感染引起的肝脏EMT和纤维化水平,这一过程可能通过抑制TGF-β1/Smad信号通路而实现。

本文引用格式

姜婷婷 , 蔚志豪 , 崔轩胤 , 莫筱瑾 , 李显 , 胡媛 . 肝脏E-钙黏蛋白过表达对日本血吸虫感染小鼠肝纤维化的影响[J]. 中国寄生虫学与寄生虫病杂志, 2026 , 44(1) : 15 -20 . DOI: 10.12140/j.issn.1000-7423.2026.01.003

Abstract

Objective To investigate the impact of E-cadherin (E-cad) overexpression on hepatic epithelial-mesenchymal transition (EMT) and liver fibrosis induced by Schistosoma japonicum infection. Methods A total of 16 mice were randomly divided into the E-cad group and the control group, and were injected with 2 × 1011 vector genomes of E-cad plasmid or empty plasmid packaged with adeno-associated virus 8 via the tail vein. All mice were infected with S. japonicum cercariae [(20 ± 1) per mouse] via the abdomen 3 weeks post-injection, and liver tissues were collected 6 weeks post-infection. Total RNA was extracted from liver tissues, and the relative transcription levels of target genes were detected with a real-time quantitative PCR (qPCR) assay. Total protein was extracted from liver tissues, and the relative expression of target proteins was detected using Western blotting. Paraffin-embedded liver sections were stained with hematoxylin and eosin (HE) and Masson’s trichrome stains to assess the area of single-egg granulomas and collagen fibers. All statistical analyses were performed using the software GraphPad Prism 9, and differences of means between groups were assessed using t-test. Results The relative mRNA transcription levels of E-cad were 1.15 ± 0.07 and 7.19 ± 2.43 in mouse liver tissues in the control and E-cad group (t = 4.30, P < 0.05), and the relative protein expression of E-cad were 1.03 ± 0.16 and 1.42 ± 0.22 in the control and E-cad group (t = 3.62, P < 0.01), indicating successful modeling of hepatic E-cad overexpression in mice. qPCR assay quantified lower relative mRNA transcription of vimentin (Vim) [(0.60 ± 0.17) vs. (1.37 ± 0.33); t = 3.60, P < 0.05], α-smooth muscle actin (α-SMA) [(0.62 ± 0.19) vs. (1.43 ± 0.35); t = 3.48, P < 0.05], collagenⅠ (Col-1) [(0.31 ± 0.17) vs. (1.78 ± 0.84); t = 3.74, P < 0.05] and collagenⅢ (Col-3) [(0.30 ± 0.13) vs. (1.78 ± 0.45); t = 5.52, P < 0.01] in mouse liver tissues in the E-cad group than in the control group, and Western blotting determined lower relative expression of Vim [(0.22 ± 0.13) vs. (0.71 ± 0.13); t = 4.39, P < 0.01], N-cadherin (N-cad) [(0.37 ± 0.14) vs. (0.65 ± 0.08); t = 2.75, P < 0.05], α-SMA [(0.29 ± 0.19) vs. (0.81 ± 0.13); t = 3.91, P < 0.01], Col-1 [(0.23 ± 0.06) vs. (0.43 ± 0.08); t = 3.99, P < 0.01], Col-3 [(0.17 ± 0.02) vs. (0.50 ± 0.16); t = 3.47, P < 0.05], transforming growth factor-β1 (TGF-β1) [(0.32 ± 0.13) vs. (0.68 ± 0.07); t = 3.92, P < 0.01], Smad2 [(0.57 ± 0.14) vs. (0.87 ± 0.04); t = 2.95, P < 0.05] and Smad3 [(0.54 ± 0.10) vs. (0.82 ± 0.06); t = 4.61, P < 0.05] in mouse liver tissues in the E-cad group than in the control group. HE staining showed that the area of single-egg liver granulomas were [(34.10 ± 6.94) × 104] and [(12.76 ± 3.16) × 104] μm2 in the control and E-cad groups (t = 7.41, P < 0.01), and Masson staining showed that the areas of collagen fibers with single-egg liver granulomas were [(8.50 ± 2.36) × 104] and [(3.65 ± 0.90) × 104] μm2 in the control and E-cad groups (t = 5.01, P < 0.01), respectively. Conclusion Hepatic E-cad overexpression alleviates EMT and liver fibrosis induced by S. japonicum infection in mice, potentially through inhibition of the TGF-β1/Smad signaling pathway.

参考文献

[1] Buonfrate D, Ferrari TCA, Adegnika AA, et al. Human schistosomiasis[J]. Lancet, 2025, 405(10479): 658-670.
[2] LoVerde PT. Schistosomiasis[J]. Adv Exp Med Biol, 2024, 1454: 75-105.
[3] 钟昊然, 金亚美. 日本血吸虫病肝纤维化的研究进展[J]. 中国动物传染病学报, 2023, 31(6): 177-183.
  Zhong HR, Jin YM. Advance on liver fibrosis induced by Schistosoma japonicum infection[J]. Chin J Vet Parasitol, 2023, 31(6): 177-183. (in Chinese)
[4] 何君逸, 张利娟, 杨帆, 等. 2024年全国血吸虫病防治进展[J]. 中国血吸虫病防治杂志(中英文), 2025, 37(3): 223-231.
  He JY, Zhang LJ, Yang F, et al. Progress of schistosomiasis control in the people’s republic of China in 2024[J]. Chin J Schisto Control, 2025, 37(3): 223-231. (in Chinese)
[5] Liu ZL, Zhang LC, Liang YM, et al. Pathology and molecular mechanisms of Schistosoma japonicum-associated liver fibrosis[J]. Front Cell Infect Microbiol, 2022, 12: 1035765.
[6] Marconi GD, Fonticoli L, Rajan TS, et al. Epithelial-mesenchymal transition (EMT): the type-2 EMT in wound healing, tissue regeneration and organ fibrosis[J]. Cells, 2021, 10(7): 1587.
[7] Zhu W, Zhu ZX, Feng J, et al. PRAG1 promotes cholangiocyte epithelial-mesenchymal transition and liver fibrosis in biliary atresia[J]. Biochim Biophys Acta Mol Basis Dis, 2025, 1871(8): 167994.
[8] Chu AS, Diaz R, Hui JJ, et al. Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis[J]. Hepatology, 2011, 53(5): 1685-1695.
[9] Chen J, Ge SJ, Feng HJ, et al. KRT17 promotes the activation of HSCs via EMT in liver fibrosis[J]. J Clin Transl Hepatol, 2022, 10(2): 207-218.
[10] McManus DP, Bergquist R, Cai PF, et al. Schistosomiasis―from immunopathology to vaccines[J]. Semin Immunopathol, 2020, 42(3): 355-371.
[11] Perera DJ, Koger-Pease C, Paulini K, et al. Beyond schistosomiasis: unraveling co-infections and altered immunity[J]. Clin Microbiol Rev, 2024, 37(1): e00098-e00023.
[12] Sisto M, Ribatti D, Lisi S. Organ fibrosis and autoimmunity: the role of inflammation in TGFβ-dependent EMT[J]. Biomolecules, 2021, 11(2): 310.
[13] Kumar V, Xin XF, Ma JY, et al. Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis[J]. Adv Drug Deliv Rev, 2021, 176: 113888.
[14] Zhang XX, Chen JC, Lin RH, et al. Lactate drives epithelial-mesenchymal transition in diabetic kidney disease via the H3K14la/KLF5 pathway[J]. Redox Biol, 2024, 75: 103246.
[15] Li MD, Chen LH, Xiang HX, et al. Benzo [a] pyrene evokes epithelial-mesenchymal transition and pulmonary fibrosis through AhR-mediated Nrf2-p62 signaling[J]. J Hazard Mater, 2024, 473: 134560.
[16] Shu GW, Yusuf A, Dai CX, et al. Piperine inhibits AML-12 hepatocyte EMT and LX-2 HSC activation and alleviates mouse liver fibrosis provoked by CCl(4): roles in the activation of the Nrf2 cascade and subsequent suppression of the TGF-β1/Smad axis[J]. Food Funct, 2021, 12(22): 11686-11703.
[17] Kong C, Qu XZ, Liu MM, et al. Dynamic interactions between E-cadherin and Ankyrin-G mediate epithelial cell polarity maintenance[J]. Nat Commun, 2023, 14(1): 6860.
[18] Nakagawa H, Hikiba Y, Hirata Y, et al. Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis[J]. Proc Natl Acad Sci USA, 2014, 111(3): 1090-1095.
[19] Jiang TT, Wu XY, Zhou H, et al. Pathological changes in hepatic sinusoidal endothelial cells in Schistosoma japonicum-infected mice[J]. Trop Med Infect Dis, 2023, 8(2): 124.
[20] So RJ, Collins SL, Chan-Li Y, et al. Localized knockout of E-cadherin in subglottic mucosa increases fibrosis[J]. Otolaryngol Head Neck Surg, 2025, 172(6): 2003-2008.
[21] Peng DD, Fu MY, Wang MN, et al. Targeting TGF-β signal transduction for fibrosis and cancer therapy[J]. Mol Cancer, 2022, 21(1): 104.
[22] Zhang CY, Zhang Y, Hu X, et al. Luteolin inhibits subretinal fibrosis and epithelial-mesenchymal transition in laser-induced mouse model via suppression of Smad2/3 and YAP signaling[J]. Phytomedicine, 2023, 116: 154865.
[23] Lee JH, Massagué J. TGF-β in developmental and fibrogenic EMTs[J]. Semin Cancer Biol, 2022, 86(Pt 2): 136-145.
文章导航

/

〈 〉